2026 Korea Metal Week, Goyang

The 2026 Korea BIX Biopharmaceutical Technology Exhibition (BIX Korea) is one of the most influential and professional annual events in the biopharmaceutical technology sector in Korea and Asia. Held annually in Seoul, the exhibition aims to bring together leading biopharmaceutical companies, research institutions, experts, scholars, and professional visitors from around the world to discuss cutting-edge industry technologies, share the latest research findings, and promote international exchange and cooperation. BIX Korea is not only a platform for showcasing the latest products and solutions but also an important window for gaining insights into industry development trends and seizing market opportunities. The exhibition is grand in scale, typically attracting hundreds of exhibitors from dozens of countries and regions worldwide, as well as tens of thousands of professional visitors. During the exhibition, in addition to extensive product displays, a series of high-level academic conferences, technical seminars, corporate roadshows, and business matching events will be held, providing exhibitors and visitors with a comprehensive interactive experience. BIX Korea plays a crucial role in promoting the development of Korea's biopharmaceutical industry and offers an excellent opportunity for international biopharmaceutical companies to enter the Korean market and expand their business in Asia. Its influence is reflected not only in the facilitation of business cooperation but also in its continuous drive for biopharmaceutical technology innovation and industrial upgrading. The main exhibiting groups include biopharmaceutical raw material suppliers, equipment manufacturers, technology service providers, R&D institutions, contract manufacturing organizations (CMO/CDMO), and biopharmaceutical companies, collectively building a vibrant biopharmaceutical ecosystem.

The exhibit range of the 2026 Korea BIX Biopharmaceutical Technology Exhibition covers all aspects of the biopharmaceutical industry chain, aiming to comprehensively showcase solutions from R&D to production, and from testing to application. Key exhibit categories include: biopharmaceutical raw materials and intermediates, such as cell culture media, sera, enzymes, antibodies, nucleic acids, buffers, excipients, etc.; bioreactors and fermentation equipment, covering laboratory-scale, pilot-scale, and industrial-scale bioreactors, fermenters, cell culture systems, agitators, sensors, etc.; separation, purification, and filtration equipment, including chromatography systems, ultrafiltration systems, microfiltration systems, membrane separation equipment, centrifuges, homogenizers, etc.; formulation equipment and packaging materials, such as lyophilizers, filling machines, tablet presses, capsule fillers, sterilization equipment, aseptic filling lines, pre-filled syringes, pharmaceutical glass vials, soft bags, etc.; analytical and quality control equipment, including high-performance liquid chromatographs (HPLC), mass spectrometers (MS), spectrometers, PCR instruments, flow cytometers, microplate readers, microbial detection systems, environmental monitoring equipment, laboratory automation systems, etc.; bioinformatics and data management solutions, such as biological data analysis software, laboratory information management systems (LIMS), electronic batch record systems (EBR), cloud computing services, etc.; cell and gene therapy technologies and equipment, including cell incubators, cell sorters, gene editing tools, viral vector production, CAR-T cell manufacturing, etc.; vaccine production technologies and equipment, covering vaccine antigen production, adjuvants, vaccine filling lines, cold chain transport solutions, etc.; biopharmaceutical contract research and manufacturing services (CRO/CDMO), providing one-stop services for drug discovery, preclinical research, clinical trials, process development, pilot production, and commercial manufacturing; and other related products and technologies, such as cleanroom equipment, consumables, regulatory consulting, intellectual property services, and biopharmaceutical park investment promotion.

No fee information available. Please contact us for a quote.